Vanguard Capital Management
KPRX icon

Vanguard Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Vanguard Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.2K Hold
19,861
– – ﹤0.01% 3933
2026
Q1 		$38.3K Buy
+19,861
New +$41.9K ﹤0.01% 3944

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Capital Management's KPRX Position: Q2 2026 in Review

Vanguard Capital Management held its Kiora Pharmaceuticals (KPRX) position steady in Q2 2026 at 19,861 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3933.

Vanguard Capital Management first reported a position in KPRX in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Vanguard Capital Management held 19,861 shares of Kiora Pharmaceuticals worth $52.2K as of Q2 2026.
  • Vanguard Capital Management left its Kiora Pharmaceuticals share count unchanged in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3933 holding.
  • Vanguard Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.